Adjuvant therapy for resected non-small-cell lung cancer: Past, present, and future

Current Oncology Reports

Volumn 7, Issue 4, 2005, Pages 248-254

  Juergens, Rosalyn A ^a   Brahmer, Julie R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BESTATIN; CELECOXIB; CISPLATIN; CYCLOPHOSPHAMIDE; DENDRITIC CELL VACCINE; DOXORUBICIN; ETOPOSIDE; GEFITINIB; IFOSFAMIDE; LEVAMISOLE; LOMUSTINE; MITOMYCIN; NAVELBINE; PACLITAXEL; PROTEIN P53; UFT; VINCRISTINE; VINDESINE; ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL OBSERVATION; CLINICAL TRIAL; DRUG TARGETING; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MEDICAL DECISION MAKING; META ANALYSIS; REVIEW; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; HISTORY; LUNG TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CLINICAL TRIALS; HISTORY, 20TH CENTURY; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 23444449316     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-005-0046-5     Document Type: Review

References (34)

1. Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10-30.
2. Immerman SC, Vanecko RM, Fry WA, et al.: Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. Ann Thorac Surg 1981, 32:23-27.
3. Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615-622.
4. Mountain CF: The international system for staging lung cancer. Semin Surg Oncol 2000, 18:106-115.
5. Postoperative radiotherapy in non-small cell lung cancer: systemic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998, 352:257-263.
6. Arriagada R, Bergman B, Dunant A, et al.: International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350:351-360.
7. Holmes EC, Gail M: Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol 1986, 4:710-715.
8. The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group. J Clin Oncol 1988, 6:9-17.
9. Feld R, Rubenstein L, Thomas PA. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. The Lung Cancer Study Group. J Natl Cancer Inst 1993, 85:299-306.
10. Niiranen A, Niitamo-Horhonen S, Kouri M, et al.: Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study. J Clin Oncol 1992, 10:1927-1932.
11. Ohta M, Tsuchiya R, Shimoyama M, et al.: Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group. J Thorac Cardiorvasc Surg 1993, 106:703-708.
12. Dautzenberg B, Chastang C, Arriagada R, et al.: Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques). Cancer 1995, 76:779-786.
13. Keller S, Adak S, Wagner H, et al.: A randomized trial of post-operative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. N Engl J Med 2000, 343:1217-1222.
14. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995, 311:899-909.
15. Scagliotti GV, Foassati R, Torri V, et al.: Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigators. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Natl Cancer Inst 2003, 95:1453-1461.
16. Waller D, Peake MD, Stephens RJ, et al.: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 2004, 26:173-182.
17. Strauss GM, Herndon J, Maddaus MA, et al.: Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage 1B non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. J Clin Oncol 2004, 22(14S):7019.
18. Winton TL, Livingston R, Johnson D, et al.: A prospective randomized trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected. stage IB and II non-small cell lung cancer (NSCLC) Intergroup JBR, 10. J Clin Oncol 2004, 22(14S):7018.
19. Tada, H, Tsuchiya R, Ichinose Y, et al.: A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG 9304). Lung Cancer 2004, 43:167-173.
20. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan). Eur J Surg Oncol 1995, 21:69-77.
21. Wada H, Hitami S, Teramatsu T: West Japan Study Group for Lung Cancer Surgery: Adjuvant chemotherapy after complete resection in non-small cell lung cancer. J Clin Oncol 1996, 14:1048-1054.
22. Wada J, Miyahara R, Tanaka F, et al.: Postoperative adjuvant chemotherapy with PVM (cisplatin + vindesine + mitomycin C) and UFT (uracil + tegafur) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. Eur J Cardiothorac Surg 1999, 15:438-443.
23. Tada H, Yasumitsu T, Iuchi K, et al.: Randomized study of adjuvant chemotherapy for completely resected non-small cell lung cancer: lack of prognostic significance in DNA ploidy pattern at adjuvant setting [abstract]. Proc ASCO 2002, 21:313: 1250. http://www.asco.org/
24. Endo C, Saito Y, Iwanami H, et al.: A randomized trial of post-operative UFT therapy in p stage I, II non-small cell lung cancer. North-east Japan Study Group for Lung Cancer Surgery. Lung Cancer 2003, 40:181-186.
25. Imaizumi M: A randomized trial of postoperative adjuvant chemotherapy for p-stage I non-small cell lung cancer (4th cooperative study) [abstract]. Lung Cancer 2003, 41:S54.
26. Kato H, Ichinose Y, Ohta M, et al.: A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004, 350:1713-1721.
27. Nakagawa M, Tanaka F, Tsubota N, et al.: A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG) - the 4th study. Ann Oncol 2005, 16:75-80.
28. Hamada C, Ohta M, Wada H, et al.: Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small-cell lung cancer. J Clin Oncol 2004, 22(14S):7002.
29. Hotta K Matsue K, Ueoka H, et al.: Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004, 22:3860-3867.
30. Sedrakyan A, vanDer Meulen J, O'Byrne Y, et al.: Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2004, 128:414-419.
31. Clinical trials.gov: A service of the National Institutes of Health. http://www.clinicaltrials.gov. Accessed January 31, 2005.
32. Ichinose Y, Genka K, Koike T, et al.: Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma. J Natl Cancer Inst 2003, 95:605-610.
33. Yasumitsu T, Ohshima S, Nakano N, et al.: Bestatin in resected lung cancer: a randomized clinical trial. Acta Oncol 1990, 29:827-831.
34. Mouritzen C: Bestatin as adjuvant treatment in operated stage I and stage II non-small cell lung cancer. European Lung Cancer Study Group. Acta Oncol 1990, 29:817-820.